Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
| gptkbp:ATCCode |
none
|
| gptkbp:CASNumber |
1626359-62-3
|
| gptkbp:developedBy |
gptkb:Pfizer
|
| gptkbp:hasClinicalTrialStatus |
investigational
|
| gptkbp:hasMolecularFormula |
C22H23N7O2S
|
| https://www.w3.org/2000/01/rdf-schema#label |
tosidotinib
|
| gptkbp:indication |
autoimmune diseases
alopecia areata |
| gptkbp:isJAKInhibitor |
true
|
| gptkbp:IUPACName |
N-(3-((1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)phenyl)-4-(methylsulfonyl)-2-pyridinamine
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
gptkb:PF-06651600
|
| gptkbp:target |
gptkb:Janus_kinase_3
|
| gptkbp:bfsParent |
gptkb:IMR-687
|
| gptkbp:bfsLayer |
8
|